ATE410677T1 - Bioäquivalenztest für eisenhaltige formulierungen - Google Patents

Bioäquivalenztest für eisenhaltige formulierungen

Info

Publication number
ATE410677T1
ATE410677T1 AT02768694T AT02768694T ATE410677T1 AT E410677 T1 ATE410677 T1 AT E410677T1 AT 02768694 T AT02768694 T AT 02768694T AT 02768694 T AT02768694 T AT 02768694T AT E410677 T1 ATE410677 T1 AT E410677T1
Authority
AT
Austria
Prior art keywords
iron
containing formulations
bioequivalence test
bioequivalence
formulations
Prior art date
Application number
AT02768694T
Other languages
English (en)
Inventor
Mary Helenek
Ralph Lange
Richard Lawrence
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32684391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE410677(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Application granted granted Critical
Publication of ATE410677T1 publication Critical patent/ATE410677T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT02768694T 2002-08-26 2002-08-26 Bioäquivalenztest für eisenhaltige formulierungen ATE410677T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/227,445 US6911342B2 (en) 2002-08-26 2002-08-26 Bioequivalence test for iron-containing formulations
PCT/US2002/026989 WO2004019032A1 (en) 2002-08-26 2002-08-26 Bioequivalence test for iron-containing formulations

Publications (1)

Publication Number Publication Date
ATE410677T1 true ATE410677T1 (de) 2008-10-15

Family

ID=32684391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02768694T ATE410677T1 (de) 2002-08-26 2002-08-26 Bioäquivalenztest für eisenhaltige formulierungen

Country Status (17)

Country Link
US (1) US6911342B2 (de)
EP (1) EP1540338B1 (de)
JP (1) JP4408807B2 (de)
KR (1) KR100908447B1 (de)
CN (1) CN1685227B (de)
AT (1) ATE410677T1 (de)
AU (1) AU2002331712A1 (de)
BR (1) BR0215853A (de)
CA (1) CA2494199C (de)
CY (1) CY1108630T1 (de)
DE (1) DE60229303D1 (de)
DK (1) DK1540338T3 (de)
ES (1) ES2315401T3 (de)
IL (1) IL167085A (de)
MX (1) MXPA05002159A (de)
PT (1) PT1540338E (de)
WO (1) WO2004019032A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
ES2394312T3 (es) 2004-03-16 2013-01-30 Navinta Llc Complejos de hierro sacarosa y método de producción de los mismos
ES2424943T3 (es) * 2004-12-06 2013-10-10 Emcure Pharmaceuticals Limited Un proceso rentable para la preparación de hierro sacarosa
JP4797900B2 (ja) * 2006-09-12 2011-10-19 三浦工業株式会社 鉄の定量方法
JP4797902B2 (ja) * 2006-09-13 2011-10-19 三浦工業株式会社 鉄の定量方法
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
US8140303B2 (en) * 2008-01-15 2012-03-20 Masato Terashita Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug
US8058076B2 (en) 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN101710113B (zh) * 2009-12-09 2013-04-03 南京生命能科技开发有限公司 一种测定铁-碳水化合物络合物浊点和游离糖缓冲系数的方法
IT1405688B1 (it) 2010-06-09 2014-01-24 Biofer Spa Nuovi complessi a basso peso molecolare tra ferro ed acido maltobionico, uso di questi per la somministrazione intramuscolare o sottocutanea nella terapia di stati anemici, e nuove composizioni farmaceutiche adatte a questi usi.
JP7320611B2 (ja) * 2019-02-28 2023-08-03 レニバス・セラピューティクス・インコーポレイテッド 新規鉄組成物及びその製造方法と使用方法
CN110551019A (zh) * 2019-09-12 2019-12-10 天津医科大学 一种亚铁糖(ⅱ)复合物、制备方法及其应用
CN118103047A (zh) 2021-08-27 2024-05-28 美国瑞根特有限公司 铁组合物及其制备和使用方法
CN114652844B (zh) * 2022-04-13 2023-10-20 南京大学 一种基于仿生学设计的纳米组装材料的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389706A (en) * 1972-05-03 1983-06-21 Westinghouse Electric Corp. Digital computer monitored and/or operated system or process which is structured for operation with an improved automatic programming process and system
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
US6624668B1 (en) * 2000-11-08 2003-09-23 Xilinx, Inc. Digitally programmable phase-lock loop for high-speed data communications
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations

Also Published As

Publication number Publication date
BR0215853A (pt) 2005-06-21
CY1108630T1 (el) 2014-04-09
CN1685227B (zh) 2013-09-04
CN1685227A (zh) 2005-10-19
JP2005536738A (ja) 2005-12-02
AU2002331712A1 (en) 2004-03-11
PT1540338E (pt) 2008-12-04
WO2004019032A1 (en) 2004-03-04
CA2494199A1 (en) 2004-03-04
KR100908447B1 (ko) 2009-07-21
IL167085A (en) 2010-06-16
JP4408807B2 (ja) 2010-02-03
US20040038416A1 (en) 2004-02-26
ES2315401T3 (es) 2009-04-01
EP1540338B1 (de) 2008-10-08
EP1540338A1 (de) 2005-06-15
US6911342B2 (en) 2005-06-28
DE60229303D1 (de) 2008-11-20
KR20050083658A (ko) 2005-08-26
MXPA05002159A (es) 2005-12-05
DK1540338T3 (da) 2009-02-09
EP1540338A4 (de) 2006-06-07
CA2494199C (en) 2007-02-06

Similar Documents

Publication Publication Date Title
CY1108630T1 (el) Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
EP1546162A4 (de) Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivitüt
DK1436427T3 (da) Fremgangsmåde og sammensætning til at vurdere antistofbehandlingsrespons
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
SG155931A1 (en) Wnt proteins and detection and treatment of cancer
SG149899A1 (en) Methods and apparatus for data analysis
TW200617369A (en) Method to inspect a wafer
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE60206923D1 (de) Kardiovaskulares sicherheitstestverfahren
WO2005012901A3 (en) Method for measuring aromatase activity
TW200508605A (en) Analysis method
AU2001263771A1 (en) An assay method and kit for testing biological material for exposure to stress using biomarkers
DE602005024254D1 (de)
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2005020005A3 (en) Providing support for structural converage testing
EP1601682A4 (de) Verbindungen und verfahren zur diagnose und behandlung von prostatakrebs
AU2002251326A1 (en) Method to analyse the kit genotype of pigs
WO2005093411A3 (en) Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxigenase and methods of using the same
DE60324820D1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo
FR2846009B1 (fr) Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
DE60329500D1 (de) Verfahren zur identifikation von salzempfindlichen personen
TW200722984A (en) Auto testing method and system
DE60315189D1 (de) Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1540338

Country of ref document: EP